查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1887034

安全采血针市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察，以及2024-2032年预测

Safety Lancets Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 请询问到货日

价格

安全采血针市场成长推动因素

随着医疗保健系统优先考虑更安全的采血和糖尿病管理解决方案，全球安全采血针市场持续快速成长。根据最新的产业评估，2024年安全采血针市场规模达10.9亿美元。预计到2025年，该市场将进一步成长至12.1亿美元，到2032年将成长近一倍，达到26亿美元，预测期内复合年增长率高达11.5%。这一持续增长的推动因素包括糖尿病盛行率的上升、家庭医疗保健的扩展以及监管机构对临床和非临床环境中安全针头操作的日益重视。

北美将在2024年占最大的市场占有率，达到37.61%，反映出该地区疾病负担沉重、健保报销力度大，以及先进安全采血针产品普及率高。美国市场受益于联邦医疗保险（Medicare）的覆盖范围，该保险为参加联邦医疗保险B部分（Medicare Part B）的胰岛素依赖型糖尿病患者每三个月报销高达300支采血针，从而维持了稳定的需求。

慢性病负担加重推动市场扩张

全球糖尿病盛行率的不断上升仍然是安全采血针普及的主要推动因素。根据健康指标与评估研究所（IHME，2023）的数据，全球有超过5亿人患有糖尿病。这种快速增长增加了对准确、频繁血糖监测的需求，显着提高了毛细血管采血安全采血针的使用量。这些设备具有防针刺伤功能，确保操作更安全，并降低病患和医护人员的感染风险。

市场也受惠于血糖自我监测 (SMBG) 的日益普及，患者越来越倾向于使用安全易用的采血针进行居家检测。例如，2023 年发表在 "印度医学专科杂誌" 上的一项研究发现，印度有 35% 的患者在家中监测血糖，凸显了医疗保健分散化的趋势。

低收入市场的成本障碍限制了其普及化

儘管安全采血针具有临床优势，但在对成本敏感的地区，它们面临挑战。安全采血针比传统采血针贵，构成了一大障碍。在英国，2020 年 NHS 的数据显示，安全采血针每 100 支的价格在 4.87 美元到 5.06 美元之间，而标准采血针每 100 支的价格在 2.37 美元到 4.22 美元之间。在发展中市场，有限的医疗保健支出和医疗器材报销额度较低阻碍了医疗器材的广泛应用和市场渗透。

家庭医疗保健需求的成长创造了巨大的机会

家庭诊断的兴起正在开闢新的成长管道。家庭用户需要便利、无痛且安全的采血工具，因此安全采血针成为理想之选。许多政府正在推广家庭慢性病管理，以减轻医院的负担，这进一步推动了需求。需要使用采血针的家用糖化血红蛋白 (HbA1c) 检测试剂盒和胆固醇检测设备的日益普及也促进了市场扩张。

细分市场概览

依类型

  • 由于其易用性和较高的临床应用率，依钮式安全采血针将在 2024 年引领市场。
  • 压力/触摸式采血针的特点是穿刺深度一致且意外暴露风险较低，其市场正在迅速扩张。

依切口类型

  • 针式采血针因其疼痛感低、安全性高且适用于频繁检测，在2024年成为主流。
  • 刀片式采血针因其采集血量较多，在新生儿筛检和干血斑 (DBS) 检测中越来越受到关注。

依年龄组

  • 由于糖化血红蛋白 (HbA1c)、胆固醇和血糖检测频率高，成人族群将在2024年占最大占有率。
  • 由于第1型糖尿病需要常规检测，儿科族群是成长最快的族群。

依应用

  • 受全球糖尿病负担日益加重的影响，血糖监测在2024年仍将是最大的应用领域。
  • 血红素检测、胆固醇分析和干血斑检测也显着促进了需求成长。

区域展望

北美（2024 年 4.1 亿美元）

糖尿病高发生率、联邦医疗保险覆盖范围广以及实力雄厚的製造商的存在是北美市场的主要推动因素。

欧洲

在先进的医疗保健体系的支持下，该地区的普及率很高。 2020年，英格兰和威尔斯的国民医疗服务体系（NHS）在安全采血针上的支出为1,342万美元。

亚太地区

中国和印度是成长最快的地区，这主要得益于两国庞大的糖尿病人口和不断扩大的国内製造业。

拉丁美洲

糖尿病患者数量的增加和家庭监测的日益普及推动了该地区的成长。

中东和非洲

政府对非传染性疾病的关注推动了该地区的逐步扩张。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场推动因素
  • 市场阻碍因素
  • 市场机遇
  • 市场趋势

第四章：主要发现

  • 主要国家/地区主要疾病盛行率（2024 年）
  • 主要国家/地区 SMBG 使用者数量（2024 年）
  • 安全采血针的进展
  • 概述：报销情况
  • 主要产业趋势（併购、合作、等等）

第五章：全球安全采血针市场分析、洞察与预测（2019-2032）

  • 市场分析、洞察与预测 - 依类型划分
    • 依钮式
    • 压力/触摸式
  • 市场分析、洞察与预测 - 依切口类型划分
    • 针头式
    • 刀片式
  • 市场分析、洞察与预测 - 依年龄组别划分
    • 成人
    • 儿童
  • 市场分析、洞察与预测 - 依应用划分
    • 血糖监测
    • 血红素检测
    • 胆固醇检测
    • 其他
  • 市场分析、洞察与预测 - 依最终用途划分用户
    • 医院和诊所
    • 家庭医疗保健
    • 其他
  • 市场分析、洞察与预测 - 依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美安全采血针市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲安全采血针市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 德国
    • 美国王国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太地区安全采血针市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲安全采血针市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

章节10：中东和非洲安全采血针市场分析、洞察与预测（2019-2032 年）

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 中东和非洲其他地区

第 11 章 竞争分析

  • 全球市占率分析（2024 年）
  • 公司简介
    • BD
    • SARSTEDT AG & Co. KG
    • Greiner Bio-One International GmbH
    • HTL-STREFA (MTD Medical Technology and Devices)
    • Terumo Medical Corporation
    • B. Braun SE
    • Abbott
    • Cardinal Health
    • YPSOMED
    • Biosense Technologies Private Limited
Product Code: FBI113261

Growth Factors of safety lancets Market

The global safety lancets market continues to expand rapidly as healthcare systems emphasize safer blood sampling and diabetes management solutions. According to the latest industry assessment, the safety lancets market size reached USD 1.09 billion in 2024. The market is projected to grow further to USD 1.21 billion in 2025 and nearly double to USD 2.60 billion by 2032, exhibiting a strong CAGR of 11.5% during the forecast period. This sustained growth stems from rising diabetes prevalence, expansion in home healthcare, and increasing regulatory focus on safe needle practices across clinical and non-clinical settings.

North America held the largest regional share of 37.61% in 2024, reflecting high disease burden, strong reimbursement support, and strong penetration of advanced safety lancet products. The U.S. market benefits significantly from Medicare coverage, which reimburses up to 300 lancets every 3 months for insulin-dependent diabetic patients under Medicare Part B, driving consistent demand.

Growing Chronic Disease Burden Driving Market Expansion

The global rise in diabetes remains the primary driver for the adoption of safety lancets. According to the Institute for Health Metrics and Evaluation (2023), over 500 million individuals worldwide live with diabetes. This surge has elevated the need for accurate and frequent blood glucose monitoring, significantly boosting the usage of safety lancets for capillary blood collection. These devices provide needle-stick protection, ensure safer handling, and reduce infection risks for both patients and healthcare providers.

The trend toward self-monitoring of blood glucose (SMBG) also supports the market, with patients increasingly preferring safe, easy-to-use lancets for home testing. In India, for example, a 2023 study published in the Indian Journal of Medical Specialties found that 35% of patients performed home glucose monitoring, highlighting the transition toward decentralized care.

Cost Barriers Limit Adoption in Low-Income Markets

Despite their clinical advantages, safety lancets face adoption challenges in cost-sensitive regions. Safety-engineered lancets are priced higher than traditional lancets, and the difference remains a barrier. In the U.K., NHS data from 2020 shows safety lancets can cost USD 4.87-5.06 per 100 units, whereas standard lancets cost USD 2.37-4.22 per 100 units. In developing markets, limited healthcare spending and low device reimbursement restrict widespread use, slowing market penetration.

Rising Home Healthcare Demand Creates Significant Opportunities

The shift toward home-based diagnostics is unlocking new growth avenues. Home-users require simple, painless, and safe blood sampling tools, making safety lancets a preferred choice. Many governments are pushing for at-home chronic disease management to reduce hospital burden, further elevating demand. Growing availability of home HbA1c kits and cholesterol testing devices, all requiring lancets, also supports market expansion.

Segmentation Overview

By Type

  • Button-activated safety lancets led the market in 2024, driven by ease of use and strong adoption in clinical settings.
  • Pressure/contact-activated lancets are expanding rapidly, offering consistent puncture depth and lower risk of accidental exposure.

By Incision Type

  • Needle lancets dominated in 2024, preferred for lower pain, enhanced safety, and suitability for frequent testing.
  • Blade lancets are gaining traction for neonatal screening and dried blood spot (DBS) tests due to their higher blood yield.

By Age Group

  • Adults accounted for the largest share in 2024, attributed to high testing volumes for HbA1c, cholesterol, and blood glucose.
  • Pediatrics is the fastest-growing segment due to daily testing needs in Type 1 diabetes.

By Application

  • Blood glucose monitoring remained the largest segment in 2024, driven by the rising global diabetes burden.
  • Hemoglobin testing, cholesterol profiling, and DBS testing also contribute significantly to demand.

Regional Outlook

North America (USD 0.41 Billion in 2024)

Dominates due to high diabetes prevalence, Medicare coverage, and strong manufacturer presence.

Europe

Strong adoption driven by advanced healthcare systems. NHS England and Wales spent USD 13.42 million on safety lancets in 2020.

Asia Pacific

Fastest-growing region, propelled by large diabetic populations in China and India, and expanding domestic manufacturing.

Latin America

Growth supported by rising diabetes cases and expanding home monitoring adoption.

Middle East & Africa

Gradual expansion driven by government focus on non-communicable diseases.

Competitive Landscape

Key market players include BD, HTL-STREFA, Abbott, SARSTEDT AG & Co. KG, Terumo Medical Corporation, Cardinal Health, B. Braun, Ypsomed, and others. Companies are focusing on product innovation, portfolio expansion, and strategic partnerships to strengthen global market presence.

Segmentation By Type

  • Button-activated
  • Pressure/Contact-activated

By Incision Type

  • Needle
  • Blade

By Age Group

  • Adult
  • Pediatric

By Application

  • Blood Glucose Monitoring
  • Hemoglobin Testing
  • Cholesterol Testing
  • Others

By End-user

  • Hospitals & Clinics
  • Home Care
  • Others

By Region

  • North America (By Type, Incision Type, Age Group, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, By Key Countries/Region, 2024
  • 4.2. Number of SMBG User, By Key Countries/Region, 2024
  • 4.3. Advancements in Safety Lancets
  • 4.4. Overview: Reimbursement Scenario
  • 4.5. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)

5. Global Safety Lancets Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Button-activated
    • 5.1.2. Pressure/Contact-activated
  • 5.2. Market Analysis, Insights and Forecast - By Incision Type
    • 5.2.1. Needle
    • 5.2.2. Blade
  • 5.3. Market Analysis, Insights and Forecast - By Age Group
    • 5.3.1. Adult
    • 5.3.2. Pediatric
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Blood Glucose Monitoring
    • 5.4.2. Hemoglobin Testing
    • 5.4.3. Cholesterol Testing
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By End-user
    • 5.5.1. Hospitals & Clinics
    • 5.5.2. Home Care
    • 5.5.3. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Safety Lancets Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Button-activated
    • 6.1.2. Pressure/Contact-activated
  • 6.2. Market Analysis, Insights and Forecast - By Incision Type
    • 6.2.1. Needle
    • 6.2.2. Blade
  • 6.3. Market Analysis, Insights and Forecast - By Age Group
    • 6.3.1. Adult
    • 6.3.2. Pediatric
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Blood Glucose Monitoring
    • 6.4.2. Hemoglobin Testing
    • 6.4.3. Cholesterol Testing
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By End-user
    • 6.5.1. Hospitals & Clinics
    • 6.5.2. Home Care
    • 6.5.3. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Safety Lancets Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Button-activated
    • 7.1.2. Pressure/Contact-activated
  • 7.2. Market Analysis, Insights and Forecast - By Incision Type
    • 7.2.1. Needle
    • 7.2.2. Blade
  • 7.3. Market Analysis, Insights and Forecast - By Age Group
    • 7.3.1. Adult
    • 7.3.2. Pediatric
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Blood Glucose Monitoring
    • 7.4.2. Hemoglobin Testing
    • 7.4.3. Cholesterol Testing
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By End-user
    • 7.5.1. Hospitals & Clinics
    • 7.5.2. Home Care
    • 7.5.3. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. Germany
    • 7.6.2. U.K.
    • 7.6.3. France
    • 7.6.4. Italy
    • 7.6.5. Spain
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia pacific Safety Lancets Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Button-activated
    • 8.1.2. Pressure/Contact-activated
  • 8.2. Market Analysis, Insights and Forecast - By Incision Type
    • 8.2.1. Needle
    • 8.2.2. Blade
  • 8.3. Market Analysis, Insights and Forecast - By Age Group
    • 8.3.1. Adult
    • 8.3.2. Pediatric
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Blood Glucose Monitoring
    • 8.4.2. Hemoglobin Testing
    • 8.4.3. Cholesterol Testing
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By End-user
    • 8.5.1. Hospitals & Clinics
    • 8.5.2. Home Care
    • 8.5.3. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Safety Lancets Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Button-activated
    • 9.1.2. Pressure/Contact-activated
  • 9.2. Market Analysis, Insights and Forecast - By Incision Type
    • 9.2.1. Needle
    • 9.2.2. Blade
  • 9.3. Market Analysis, Insights and Forecast - By Age Group
    • 9.3.1. Adult
    • 9.3.2. Pediatric
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Blood Glucose Monitoring
    • 9.4.2. Hemoglobin Testing
    • 9.4.3. Cholesterol Testing
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By End-user
    • 9.5.1. Hospitals & Clinics
    • 9.5.2. Home Care
    • 9.5.3. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Safety Lancets Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Button-activated
    • 10.1.2. Pressure/Contact-activated
  • 10.2. Market Analysis, Insights and Forecast - By Incision Type
    • 10.2.1. Needle
    • 10.2.2. Blade
  • 10.3. Market Analysis, Insights and Forecast - By Age Group
    • 10.3.1. Adult
    • 10.3.2. Pediatric
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Blood Glucose Monitoring
    • 10.4.2. Hemoglobin Testing
    • 10.4.3. Cholesterol Testing
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By End-user
    • 10.5.1. Hospitals & Clinics
    • 10.5.2. Home Care
    • 10.5.3. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. BD
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. SARSTEDT AG & Co. KG
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Greiner Bio-One International GmbH
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. HTL-STREFA (MTD Medical Technology and Devices)
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Terumo Medical Corporation
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. B. Braun SE
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Abbott
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Cardinal Health
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. YPSOMED
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Biosense Technologies Private Limited
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1:Global Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 2:Global Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2019-2032
  • Table 3:Global Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 4:Global Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 5:Global Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 6:Global Safety Lancets Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 7:North America Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 8:North America Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2019-2032
  • Table 9:North America Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 10:North America Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 11:North America Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 12:North America Safety Lancets Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 13:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 14:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2019-2032
  • Table 15:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 16:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 17:Europe Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 18:Europe Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 19:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 20:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2019-2032
  • Table 21:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 22:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 23:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 24:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 25:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 26:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2019-2032
  • Table 27:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 28:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 29:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 30:Latin America Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 31:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 32:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2019-2032
  • Table 33:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 34:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 35:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 36:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1:Global Safety Lancets Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2:Global Safety Lancets Market Value Share (%), by Type, 2024 & 2032
  • Figure 3:Global Safety Lancets Market Value Share (%), by Incision Type, 2024 & 2032
  • Figure 4:Global Safety Lancets Market Value Share (%), by Age Group, 2024 & 2032
  • Figure 5:Global Safety Lancets Market Value Share (%), by Application, 2024 & 2032
  • Figure 6:Global Safety Lancets Market Value Share (%), by End-user, 2024 & 2032
  • Figure 7:Global Safety Lancets Market Value (USD billion), by Region, 2024 & 2032
  • Figure 8:North America Safety Lancets Market Value (USD billion), by Type, 2024 & 2032
  • Figure 9:North America Safety Lancets Market Value Share (%), by Type, 2024
  • Figure 10:North America Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 11:North America Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 12:North America Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 13:North America Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 14:North America Safety Lancets Market Value (USD billion), by Application, 2024 & 2032
  • Figure 15:North America Safety Lancets Market Value Share (%), by Application, 2024
  • Figure 16:North America Safety Lancets Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 17:North America Safety Lancets Market Value Share (%), by End-user, 2024
  • Figure 18:North America Safety Lancets Market Value (USD billion), By Country, 2024 & 2032
  • Figure 19:North America Safety Lancets Market Value Share (%), By Country, 2024
  • Figure 20:Europe Safety Lancets Market Value (USD billion), by Type, 2024 & 2032
  • Figure 21:Europe Safety Lancets Market Value Share (%), by Type, 2024
  • Figure 22:Europe Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 23:Europe Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 24:Europe Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 25:Europe Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 26:Europe Safety Lancets Market Value (USD billion), by Application, 2024 & 2032
  • Figure 27:Europe Safety Lancets Market Value Share (%), by Application, 2024
  • Figure 28:Europe Safety Lancets Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 29:Europe Safety Lancets Market Value Share (%), by End-user, 2024
  • Figure 30:Europe Safety Lancets Market Value (USD billion), By Country/Sub-region, 2024 & 2032
  • Figure 31:Europe Safety Lancets Market Value Share (%), By Country/Sub-region, 2024
  • Figure 32:Asia Pacific Safety Lancets Market Value (USD billion), by Type, 2024 & 2032
  • Figure 33:Asia Pacific Safety Lancets Market Value Share (%), by Type, 2024
  • Figure 34:Asia Pacific Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 35:Asia Pacific Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 36:Asia Pacific Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 37:Asia Pacific Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 38:Asia Pacific Safety Lancets Market Value (USD billion), by Application, 2024 & 2032
  • Figure 39:Asia Pacific Safety Lancets Market Value Share (%), by Application, 2024
  • Figure 40:Asia Pacific Safety Lancets Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 41:Asia Pacific Safety Lancets Market Value Share (%), by End-user, 2024
  • Figure 42:Asia Pacific Safety Lancets Market Value (USD billion), By Country/Sub-region, 2024 & 2032
  • Figure 43:Asia Pacific Safety Lancets Market Value Share (%), By Country/Sub-region, 2024
  • Figure 44:Latin America Safety Lancets Market Value (USD billion), by Type, 2024 & 2032
  • Figure 45:Latin America Safety Lancets Market Value Share (%), by Type, 2024
  • Figure 46:Latin America Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 47:Latin America Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 48:Latin America Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 49:Latin America Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 50:Latin America Safety Lancets Market Value (USD billion), by Application, 2024 & 2032
  • Figure 51:Latin America Safety Lancets Market Value Share (%), by Application, 2024
  • Figure 52:Latin America Safety Lancets Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 53:Latin America Safety Lancets Market Value Share (%), by End-user, 2024
  • Figure 54:Latin America Safety Lancets Market Value (USD billion), By Country/Sub-region, 2024 & 2032
  • Figure 55:Latin America Safety Lancets Market Value Share (%), By Country/Sub-region, 2024
  • Figure 56:Middle East & Africa Safety Lancets Market Value (USD billion), by Type, 2024 & 2032
  • Figure 57:Middle East & Africa Safety Lancets Market Value Share (%), by Type, 2024
  • Figure 58:Middle East & Africa Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 59:Middle East & Africa Safety Lancets Market Value Share (%), by Incision Type, 2024
  • Figure 60:Middle East & Africa Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 61:Middle East & Africa Safety Lancets Market Value Share (%), by Age Group, 2024
  • Figure 62:Middle East & Africa Safety Lancets Market Value (USD billion), by Application, 2024 & 2032
  • Figure 63:Middle East & Africa Safety Lancets Market Value Share (%), by Application, 2024
  • Figure 64:Middle East & Africa Safety Lancets Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 65:Middle East & Africa Safety Lancets Market Value Share (%), by End-user, 2024
  • Figure 66:Middle East & Africa Safety Lancets Market Value (USD billion), By Country/Sub-region, 2024 & 2032
  • Figure 67:Middle East & Africa Safety Lancets Market Value Share (%), By Country/Sub-region, 2024
  • Figure 68:Global Safety Lancets Market Share (%), By Company, 2024